GUERBET (GBT.PA) Stock Fundamental Analysis
EPA:GBT - Euronext Paris - Matif - FR0000032526 - Common Stock - Currency: EUR
Overall GBT gets a fundamental rating of 4 out of 10. We evaluated GBT against 58 industry peers in the Health Care Equipment & Supplies industry. GBT has an average financial health and profitability rating. GBT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year GBT was profitable.
In the past year GBT had a positive cash flow from operations.
Of the past 5 years GBT 4 years were profitable.
GBT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of GBT (1.55%) is comparable to the rest of the industry.
The Return On Equity of GBT (4.08%) is comparable to the rest of the industry.
GBT has a Return On Invested Capital (4.48%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GBT is below the industry average of 8.41%.
The last Return On Invested Capital (4.48%) for GBT is above the 3 year average (4.08%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 4.08% | ||
| ROIC | 4.48% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
1.3 Margins
GBT has a Profit Margin (1.91%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of GBT has declined.
With a Operating Margin value of 5.89%, GBT perfoms like the industry average, outperforming 46.55% of the companies in the same industry.
In the last couple of years the Operating Margin of GBT has declined.
GBT has a Gross Margin of 77.94%. This is amongst the best in the industry. GBT outperforms 84.48% of its industry peers.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.89% | ||
| PM (TTM) | 1.91% | ||
| GM | 77.94% |
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBT is destroying value.
GBT has about the same amout of shares outstanding than it did 1 year ago.
GBT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for GBT is higher compared to a year ago.
2.2 Solvency
GBT has an Altman-Z score of 2.17. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.17) which is in line with its industry peers.
The Debt to FCF ratio of GBT is 16.18, which is on the high side as it means it would take GBT, 16.18 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GBT (16.18) is comparable to the rest of the industry.
GBT has a Debt/Equity ratio of 0.89. This is a neutral value indicating GBT is somewhat dependend on debt financing.
The Debt to Equity ratio of GBT (0.89) is worse than 72.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 16.18 | ||
| Altman-Z | 2.17 |
ROIC/WACC0.69
WACC6.53%
2.3 Liquidity
GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
GBT's Current ratio of 2.32 is fine compared to the rest of the industry. GBT outperforms 72.41% of its industry peers.
GBT has a Quick Ratio of 1.13. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
GBT has a Quick ratio (1.13) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The earnings per share for GBT have decreased strongly by -34.20% in the last year.
Measured over the past years, GBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.50% on average per year.
GBT shows a small growth in Revenue. In the last year, the Revenue has grown by 7.05%.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
3.2 Future
The Earnings Per Share is expected to grow by 7.05% on average over the next years.
Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 3.37% on average per year.
EPS Next Y-1.67%
EPS Next 2Y8.02%
EPS Next 3Y7.05%
EPS Next 5YN/A
Revenue Next Year2.52%
Revenue Next 2Y3.1%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
GBT is valuated correctly with a Price/Earnings ratio of 16.61.
Compared to the rest of the industry, the Price/Earnings ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 82.76% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.35. GBT is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 8.34, the valuation of GBT can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 94.83% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.20, GBT is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.61 | ||
| Fwd PE | 8.34 |
4.2 Price Multiples
93.10% of the companies in the same industry are more expensive than GBT, based on the Enterprise Value to EBITDA ratio.
94.83% of the companies in the same industry are more expensive than GBT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.01 | ||
| EV/EBITDA | 4 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.02%
EPS Next 3Y7.05%
5. Dividend
5.1 Amount
GBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:GBT (5/28/2025, 5:24:13 PM)
21.1
+0.75 (+3.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners18.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap266.70M
Analysts75
Price Target27.8 (31.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP39.2%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-22.69%
PT rev (3m)-34.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-23.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.08%
Revenue NY rev (3m)-3.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.61 | ||
| Fwd PE | 8.34 | ||
| P/S | 0.32 | ||
| P/FCF | 11.01 | ||
| P/OCF | 3.28 | ||
| P/B | 0.68 | ||
| P/tB | 0.93 | ||
| EV/EBITDA | 4 |
EPS(TTM)1.27
EY6.02%
EPS(NY)2.53
Fwd EY11.99%
FCF(TTM)1.92
FCFY9.08%
OCF(TTM)6.43
OCFY30.45%
SpS66.54
BVpS31.19
TBVpS22.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 4.08% | ||
| ROCE | 6.33% | ||
| ROIC | 4.48% | ||
| ROICexc | 5.17% | ||
| ROICexgc | 6.14% | ||
| OM | 5.89% | ||
| PM (TTM) | 1.91% | ||
| GM | 77.94% | ||
| FCFM | 2.88% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.66%
ROICexc(5y)4.72%
ROICexgc(3y)5.5%
ROICexgc(5y)6.1%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexcg growth 3Y-4.7%
ROICexcg growth 5Y-5.56%
ROICexc growth 3Y2.24%
ROICexc growth 5Y-2.35%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 16.18 | ||
| Debt/EBITDA | 2.86 | ||
| Cap/Depr | 77.91% | ||
| Cap/Sales | 6.78% | ||
| Interest Coverage | 2.42 | ||
| Cash Conversion | 66.19% | ||
| Profit Quality | 150.63% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 2.17 |
F-Score5
WACC6.53%
ROIC/WACC0.69
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
EPS Next Y-1.67%
EPS Next 2Y8.02%
EPS Next 3Y7.05%
EPS Next 5YN/A
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
Revenue Next Year2.52%
Revenue Next 2Y3.1%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
EBIT growth 1Y28.18%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year108.81%
EBIT Next 3Y33.55%
EBIT Next 5YN/A
FCF growth 1Y182.76%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y196.03%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%